Up-regulated estrogen receptor β2 in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 53, Issue 1, 2012, Pages 139-144

  Yakimchuk, Konstantin ^a   Norin, Stefan ^b   Kimby, Eva ^b   Hägglund, Hans ^b   Warner, Margaret ^c   Gustafsson, Jan Åke ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c University of Houston   (United States)

Author keywords

Lymphocytes; Lymphoid leukemia; Pharmacotherapeutics

Indexed keywords

CD19 ANTIGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA 1; ESTROGEN RECEPTOR BETA 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTES, MONONUCLEAR; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PROTEIN ISOFORMS; UP-REGULATION; YOUNG ADULT;

EID: 84855454903     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.605187     Document Type: Article

References (31)

1. G, Gardiner AC, Mould SJ, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002;100:1177-1184. (Pubitemid 34864269)
2. Shim GJ, Kis LL, Warner M, et al. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc Natl Acad Sci USA 2004;101:1720-1724. (Pubitemid 38236168)
3. Shim GJ, Wang L, Andersson S, et al. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease Natl Acad Sci USA 2003;100:6694-6699.
4. N ilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-1565. (Pubitemid 32951806)
5. M atthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 2003;3:281-292.
6. Z hao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal 2008;6:e003.
7. O gawa S, Inoue S, Watanabe T, et al. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res 1998;26:3505-3512. (Pubitemid 28347221)
8. Z hao C, Matthews J, Tujague M, et al. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res 2007;67:3955-3962. (Pubitemid 46762185)
9. E sslimani-Sahla M, Kramar A, Simony-Lafontaine J, et al. Increased estrogen receptor betacx expression during mammary carcinogenesis. Clin Cancer Res 2005;11:3170-3174. (Pubitemid 40637201)
10. S aji S, Omoto Y, Shimizu C, et al. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specifi c correlation with progesterone receptor. Cancer Res 2002;62:4849-4853. (Pubitemid 34984402)
11. S him GJ, Gherman D, Kim HJ, et al. Diff erential expression of oestrogen receptors in human secondary lymphoid tissues. J Pathol 2006;208:408-414. (Pubitemid 43210528)
12. P hiel KL, Henderson RA, Adelman SJ, et al. Diff erential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 2005;97:107-113. (Pubitemid 40038861)
13. R osen ST, Maciorowski Z, Wittlin F, et al. Estrogen receptor analysis in chronic lymphocytic leukemia. Blood 1983;62:996-999. (Pubitemid 14237320)
14. Z aniboni A, Di Lorenzo D, Simoncini E, et al. Estrogen and progesterone receptor guideline for tamoxifen therapy in chronic lymphocytic leukemia: a pilot study. Acta Haematol 1986;75:92-95. (Pubitemid 16071284)
15. M elo N, Hobday C, Dowsett M, et al. Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methods. Leuk Res 1990;14: 949-952.
16. S imonsson B, Terenius L, Nilsson K. Glucocorticoid receptors, clinical characteristics, and implications for prognosis in chronic lymphocytic leukemia. Cancer 1982;49:2493-2496. (Pubitemid 12125039)
17. K uiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-5930. (Pubitemid 26190778)
18. H allek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446-5456.
19. S aji S, Jensen EV, Nilsson S, et al. Estrogen receptors alpha and beta in the rodent mammary gland. Proc Natl Acad Sci USA 2000;97:337-342. (Pubitemid 30055832)
20. Shim GJ, Warner M, Kim HJ, et al. Aromatase-defi cient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren ' s syndrome. Proc Natl Acad Sci USA 2004;101: 12628-12633. (Pubitemid 39127516)
21. G irault I, Andrieu C, Tozlu S, et al. Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma. Cancer Lett 2004;215:101-112. (Pubitemid 39221465)
22. S tygar D, Westlund P, Eriksson H, et al. Identifi cation of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes. Clin Endocrinol (Oxf ) 2006;64:74-81.
23. Xu Q, Lee C. Discovery of novel splice forms and functional analysis of cancer-specifi c alternative splicing in human expressed sequences. Nucleic Acids Res 2003;31:5635-5643. (Pubitemid 37441935)
24. S trom A, Hartman J, Foster JS, et al. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 2004;101:1566-1571. (Pubitemid 38236167)
25. Hartman J, Lindberg K, Morani A, et al. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 2006;66:11207-11213. (Pubitemid 46009948)
26. Liu MM, Albanese C, Anderson CM, et al. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 2002;277:24353-24360. (Pubitemid 34951956)
27. B urger JA, Tsukada N, Burger M, et al. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000;96: 2655-2663.
28. K uiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263. (Pubitemid 28513713)
29. Mansour A, Chang VT, Srinivas S, et al. Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fl udarabine/genistein. Cancer Immunol Immunother 2007;56: 501-514. (Pubitemid 46204536)
30. M cCall JL, Burich RA, Mack PC. GCP, a genistein-rich compound, inhibits proliferation and induces apoptosis in lymphoma cell lines. Leuk Res 2010;34:69-76.
31. Y akimchuk K, Iravani M, Hasni MS, et al. Eff ect of ligandactivated estrogen receptor β on lymphoma growth in vitro and in vivo. Leukemia. 2011;25:1103-1110.